You can buy or sell STOK and other stocks, options, ETFs, and crypto commission-free!
Stoke Therapeutics, Inc. engages in the research and development of treatments for genetic diseases. It is a biotechnology firm that focuses to increase gene expression to treat severe genetic diseases, including genetic conditions affecting the central nervous system, eye, ear, kidney, and liver. Read More The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
52 Week High
52 Week Low
-$0.27 per share
-$0.26 per share